Spironolactone, early eGFR dip, and clinical outcomes in patients with heart failure with preserved ejection fraction: insights from TOPCAT Americas

Back

HFA Premium Access

Spironolactone, early eGFR dip, and clinical outcomes in patients with heart failure with preserved ejection fraction: insights from TOPCAT Americas

Session: Cardiovascular disease in special populations

Topic: Renal Failure and Cardiovascular Disease

Speaker: Doctor I. Beldhuis (Groningen, NL)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Iris Eline Beldhuis

University Medical Centre Groningen, Groningen (Netherlands (The))

1 presentation

0 follower

5 more presentations in this session

The hidden trick in utilizing right ventricular function as a predictor of peripartum cardiomyopathy recovery: a single centre prospective cohort study

Speaker: Doctor S. Sakasasmita (Bandung, ID) Doctor H. Prameswari (Bandung, ID)

Increased cardiac and splenic 18F-FDG activity in patients with peripartum cardiomyopathy.

Speaker: Doctor J. Hoevelmann (Homburg, DE)

Pregnancy and inherited cardiovascular conditions: insights from specialized care

Speaker: Doctor M. Casian (London, GB)

Uraemic cardiomyopathy: an insight into haemodynamics and congestion in heart failure with preserved ejection fraction through the effects of haemodialysis

Speaker: Doctor S. Ng (London, GB)

Arteriovenous fistula: the second heart

Speaker: Ms V. Samsone (Vilnius, LT)

Access the full session

Cardiovascular disease in special populations

Speakers: Doctor I. Beldhuis, Doctor S. Sakasasmita, Doctor H. Prameswari, Doctor J. Hoevelmann, Doctor M. Casian...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources